JOURNAL OF JAPANESE ASSOCIATION OF VETERINARY NEPHROLOGY AND UROLOGY
Online ISSN : 2434-0146
Print ISSN : 1883-2652
Volume 10, Issue 1
Displaying 1-7 of 7 articles from this issue
Original
  • Ryota GOMI, Mika MISHINA, Waka HORIE, Toshifumi WATANABE
    2018 Volume 10 Issue 1 Pages 4-10
    Published: 2018
    Released on J-STAGE: May 11, 2018
    JOURNAL FREE ACCESS
    Cystoscopic findings of 36 dogs with cystoscopically confirmed bladder mass were evaluated. Transitional cell carcinomas (TCCs) were typically observed as nonpedunculated, elevated masses of irregular shapes and sizes, with some appearing as sea anemone-like or polypoid masses. Histopathological diagnosis other than TCC was less frequent but also had characteristic cystoscopic findings. When 34 elevated lesions were classified morphologically according to the human bladder cancer classification system, TCCs were most likely classified as a papillary sessile type, while other lesions tended to fall under different morphological types. These results suggest that the cystoscopic appearance may provide valuable information in differential diagnosis of bladder mass. The morphological classification system used in the study also seems useful for describing and evaluating clinical data, although further studies are necessary to evaluate its relevance in canine cases.
    Download PDF (3217K)
Review article
  • Satomi IWAI
    2018 Volume 10 Issue 1 Pages 12-22
    Published: 2018
    Released on J-STAGE: May 11, 2018
    JOURNAL FREE ACCESS
    Although recombinant human erythropoietin products are available for anemia of CKD in cats, the problem is the production of anti-erythropoietin antibodies with the subsequent development of aplastic anemia. Recently, it has been suggested that the disorder of iron metabolism is associated with a resistance to erythrocyte-stimulating analogues. In particular, hepcidin is considered as the central regulator of systemic iron homeostasis and mediator of anemia of inflammation. In this report, because it is important to reveal the iron status of anemia of CKD in cats in order to overcome the ESA resistance, it is detailed as follows.
    Download PDF (2138K)
  • Yuichi MIYAGAWA
    2018 Volume 10 Issue 1 Pages 23-29
    Published: 2018
    Released on J-STAGE: May 11, 2018
    JOURNAL FREE ACCESS
    Renal anemia is a common complication with advanced chronic kidney disease (CKD) in dogs and cats. In cats with CKD, renal anemia has been associated with shorter survival. The presence of moderate to severe anemia may affect quality of life (QOL) in CKD patients. Therefore, successful treatment on anemia can lead to improved QOL, delayed a progression of CKD, and increased survival times in dogs and cats with CKD. Etiological factors in renal anemia include a functional and/or absolute iron deficient, as well as decreased renal erythropoietin production. Thus, erythropoietin administration with iron supply is recommended for the treatment of renal anemia in dogs and cats with CKD. However, information on iron status and other pathogenesis in renal anemia are limited in veterinary medicine. Further studies are warranted to define the diagnosis and treatment strategy on renal anemia in dogs and cats with CKD.
    Download PDF (1020K)
  • Shigeki YAMANO
    2018 Volume 10 Issue 1 Pages 30-35
    Published: 2018
    Released on J-STAGE: May 11, 2018
    JOURNAL FREE ACCESS
    Renal anemia is seen in 30 〜 65% of cats with chronic kidney disease (CKD). Renal anemia has been identified as independent risk factor for progression of CKD. Therefore, treatment of renal anemia have important implications in cats with CKD. The use of erythropoiesis stimulating agents (ESA) is recommended in treatment of renal anemia. ESA improve quality of life and metabolic function in cats with CKD. However, the use of ESA can create a number of complications, such as iron deficiency, thromboembolism, hypertension and pure red cell aplasia (PRCA).
    Download PDF (1237K)
notes
feedback
Top